 | • レポートコード：D005-00141 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、画期的治療薬（BT）指定の世界市場を広く調査・分析し、今後の市場展望をまとめております。画期的治療薬（BT）指定の種類別市場規模（腫瘍学、感染症、希少疾患、自己免疫疾患、肺疾患、神経疾患、その他）、用途別市場規模（病院、クリニック、研究所、研究室）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、Sanofi、Janssen、Abbvie、Gilead、Novartis International AG、Acadia、Eli Lilly、BMS、Regeneron、Vertex、Jazz Pharmaceuticals、Boehringer Ingelheim、Eisai、Alexion、GlaxoSmithKline、Amgen、Exelixis、Merck、AstraZeneca、Takeda、Pfizer ・地域別グローバル市場分析 2015年-2020年 ・画期的治療薬（BT）指定の北米市場（アメリカ、カナダ、メキシコ） ・画期的治療薬（BT）指定のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・画期的治療薬（BT）指定のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・画期的治療薬（BT）指定の南米市場（ブラジル、アルゼンチン） ・画期的治療薬（BT）指定の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：腫瘍学、感染症、希少疾患、自己免疫疾患、肺疾患、神経疾患、その他 ・用途別分析：病院、クリニック、研究所、研究室 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Breakthrough Therapy (BT) Designation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.7% in the forecast period of 2020 to 2025 and will expected to reach USD 69830 million by 2025, from USD 51990 million in 2019.
The Breakthrough Therapy (BT) Designation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Breakthrough Therapy (BT) Designation market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Breakthrough Therapy (BT) Designation market has been segmented into:
Oncology
Infectious Diseases
Rare Diseases
Autoimmune Diseases
Pulmonary Diseases
Neurological Disorders
Others
By Application, Breakthrough Therapy (BT) Designation has been segmented into:
Hospital
Clinic
Research Institute
Laboratories
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Breakthrough Therapy (BT) Designation market presented in the report. This section sheds light on the sales growth of different regional and country-level Breakthrough Therapy (BT) Designation markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Breakthrough Therapy (BT) Designation market.
The report offers in-depth assessment of the growth and other aspects of the Breakthrough Therapy (BT) Designation market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Breakthrough Therapy (BT) Designation Market Share Analysis
Breakthrough Therapy (BT) Designation competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Breakthrough Therapy (BT) Designation sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Breakthrough Therapy (BT) Designation sales, revenue and market share for each player covered in this report.
The major players covered in Breakthrough Therapy (BT) Designation are:
Roche
Sanofi
Janssen
Abbvie
Gilead
Novartis International AG
Acadia
Eli Lilly
BMS
Regeneron
Vertex
Jazz Pharmaceuticals
Boehringer Ingelheim
Eisai
Alexion
GlaxoSmithKline
Amgen
Exelixis
Merck
AstraZeneca
Takeda
Pfizer
Table of Contents
1 Breakthrough Therapy (BT) Designation Market Overview
1.1 Product Overview and Scope of Breakthrough Therapy (BT) Designation
1.2 Classification of Breakthrough Therapy (BT) Designation by Type
1.2.1 Global Breakthrough Therapy (BT) Designation Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type in 2019
1.2.3 Oncology
1.2.4 Infectious Diseases
1.2.5 Rare Diseases
1.2.6 Autoimmune Diseases
1.2.7 Pulmonary Diseases
1.2.8 Neurological Disorders
1.2.9 Others
1.3 Global Breakthrough Therapy (BT) Designation Market by Application
1.3.1 Overview: Global Breakthrough Therapy (BT) Designation Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institute
1.3.5 Laboratories
1.4 Global Breakthrough Therapy (BT) Designation Market by Regions
1.4.1 Global Breakthrough Therapy (BT) Designation Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Breakthrough Therapy (BT) Designation (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Breakthrough Therapy (BT) Designation Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.3 Janssen
2.3.1 Janssen Details
2.3.2 Janssen Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Janssen SWOT Analysis
2.3.4 Janssen Product and Services
2.3.5 Janssen Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.4 Abbvie
2.4.1 Abbvie Details
2.4.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Abbvie SWOT Analysis
2.4.4 Abbvie Product and Services
2.4.5 Abbvie Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.5 Gilead
2.5.1 Gilead Details
2.5.2 Gilead Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Gilead SWOT Analysis
2.5.4 Gilead Product and Services
2.5.5 Gilead Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis International AG
2.6.1 Novartis International AG Details
2.6.2 Novartis International AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis International AG SWOT Analysis
2.6.4 Novartis International AG Product and Services
2.6.5 Novartis International AG Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.7 Acadia
2.7.1 Acadia Details
2.7.2 Acadia Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Acadia SWOT Analysis
2.7.4 Acadia Product and Services
2.7.5 Acadia Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Eli Lilly SWOT Analysis
2.8.4 Eli Lilly Product and Services
2.8.5 Eli Lilly Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.9 BMS
2.9.1 BMS Details
2.9.2 BMS Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 BMS SWOT Analysis
2.9.4 BMS Product and Services
2.9.5 BMS Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.10 Regeneron
2.10.1 Regeneron Details
2.10.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Regeneron SWOT Analysis
2.10.4 Regeneron Product and Services
2.10.5 Regeneron Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.11 Vertex
2.11.1 Vertex Details
2.11.2 Vertex Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Vertex SWOT Analysis
2.11.4 Vertex Product and Services
2.11.5 Vertex Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.12 Jazz Pharmaceuticals
2.12.1 Jazz Pharmaceuticals Details
2.12.2 Jazz Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Jazz Pharmaceuticals SWOT Analysis
2.12.4 Jazz Pharmaceuticals Product and Services
2.12.5 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.13 Boehringer Ingelheim
2.13.1 Boehringer Ingelheim Details
2.13.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Boehringer Ingelheim SWOT Analysis
2.13.4 Boehringer Ingelheim Product and Services
2.13.5 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.14 Eisai
2.14.1 Eisai Details
2.14.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Eisai SWOT Analysis
2.14.4 Eisai Product and Services
2.14.5 Eisai Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.15 Alexion
2.15.1 Alexion Details
2.15.2 Alexion Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Alexion SWOT Analysis
2.15.4 Alexion Product and Services
2.15.5 Alexion Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.16 GlaxoSmithKline
2.16.1 GlaxoSmithKline Details
2.16.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 GlaxoSmithKline SWOT Analysis
2.16.4 GlaxoSmithKline Product and Services
2.16.5 GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.17 Amgen
2.17.1 Amgen Details
2.17.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Amgen SWOT Analysis
2.17.4 Amgen Product and Services
2.17.5 Amgen Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.18 Exelixis
2.18.1 Exelixis Details
2.18.2 Exelixis Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Exelixis SWOT Analysis
2.18.4 Exelixis Product and Services
2.18.3 Exelixis Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.19 Merck
2.19.1 Merck Details
2.19.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Merck SWOT Analysis
2.19.4 Merck Product and Services
2.19.5 Merck Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.20 AstraZeneca
2.20.1 AstraZeneca Details
2.20.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 AstraZeneca SWOT Analysis
2.20.4 AstraZeneca Product and Services
2.20.5 AstraZeneca Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.21 Takeda
2.21.1 Takeda Details
2.21.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Takeda SWOT Analysis
2.21.4 Takeda Product and Services
2.21.5 Takeda Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
2.22 Pfizer
2.22.1 Pfizer Details
2.22.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Pfizer SWOT Analysis
2.22.4 Pfizer Product and Services
2.22.5 Pfizer Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Breakthrough Therapy (BT) Designation Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Breakthrough Therapy (BT) Designation Players Market Share
3.2.2 Top 10 Breakthrough Therapy (BT) Designation Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Breakthrough Therapy (BT) Designation Revenue and Market Share by Regions
4.2 North America Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
4.3 Europe Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
4.5 South America Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
5 North America Breakthrough Therapy (BT) Designation Revenue by Countries
5.1 North America Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
5.2 USA Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
5.3 Canada Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
5.4 Mexico Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
6 Europe Breakthrough Therapy (BT) Designation Revenue by Countries
6.1 Europe Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
6.2 Germany Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
6.3 UK Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
6.4 France Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
6.5 Russia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
6.6 Italy Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Breakthrough Therapy (BT) Designation Revenue by Countries
7.1 Asia-Pacific Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
7.2 China Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
7.3 Japan Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
7.4 Korea Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
7.5 India Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
8 South America Breakthrough Therapy (BT) Designation Revenue by Countries
8.1 South America Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
8.2 Brazil Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
8.3 Argentina Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Breakthrough Therapy (BT) Designation by Countries
9.1 Middle East & Africa Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
9.2 Saudi Arabia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
9.3 UAE Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
9.4 Egypt Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
9.5 South Africa Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Breakthrough Therapy (BT) Designation Revenue and Market Share by Type (2015-2020)
10.2 Global Breakthrough Therapy (BT) Designation Market Forecast by Type (2019-2024)
10.3 Oncology Revenue Growth Rate (2015-2025)
10.4 Infectious Diseases Revenue Growth Rate (2015-2025)
10.5 Rare Diseases Revenue Growth Rate (2015-2025)
10.6 Autoimmune Diseases Revenue Growth Rate (2015-2025)
10.7 Pulmonary Diseases Revenue Growth Rate (2015-2025)
10.8 Neurological Disorders Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Breakthrough Therapy (BT) Designation Market Segment by Application
11.1 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Application (2015-2020)
11.2 Breakthrough Therapy (BT) Designation Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Research Institute Revenue Growth (2015-2020)
11.6 Laboratories Revenue Growth (2015-2020)
12 Global Breakthrough Therapy (BT) Designation Market Size Forecast (2021-2025)
12.1 Global Breakthrough Therapy (BT) Designation Market Size Forecast (2021-2025)
12.2 Global Breakthrough Therapy (BT) Designation Market Forecast by Regions (2021-2025)
12.3 North America Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
12.4 Europe Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
12.6 South America Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Breakthrough Therapy (BT) Designation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Breakthrough Therapy (BT) Designation Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Breakthrough Therapy (BT) Designation Major Business
Table 7. Roche Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Breakthrough Therapy (BT) Designation Product and Solutions
Table 10. Roche Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi Corporate Information, Location and Competitors
Table 12. Sanofi Breakthrough Therapy (BT) Designation Major Business
Table 13. Sanofi Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi SWOT Analysis
Table 15. Sanofi Breakthrough Therapy (BT) Designation Product and Solutions
Table 16. Sanofi Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Janssen Corporate Information, Location and Competitors
Table 18. Janssen Breakthrough Therapy (BT) Designation Major Business
Table 19. Janssen Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 20. Janssen SWOT Analysis
Table 21. Janssen Breakthrough Therapy (BT) Designation Product and Solutions
Table 22. Janssen Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Abbvie Corporate Information, Location and Competitors
Table 24. Abbvie Breakthrough Therapy (BT) Designation Major Business
Table 25. Abbvie Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 26. Abbvie SWOT Analysis
Table 27. Abbvie Breakthrough Therapy (BT) Designation Product and Solutions
Table 28. Abbvie Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Gilead Corporate Information, Location and Competitors
Table 30. Gilead Breakthrough Therapy (BT) Designation Major Business
Table 31. Gilead Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 32. Gilead SWOT Analysis
Table 33. Gilead Breakthrough Therapy (BT) Designation Product and Solutions
Table 34. Gilead Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Novartis International AG Corporate Information, Location and Competitors
Table 36. Novartis International AG Breakthrough Therapy (BT) Designation Major Business
Table 37. Novartis International AG Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 38. Novartis International AG SWOT Analysis
Table 39. Novartis International AG Breakthrough Therapy (BT) Designation Product and Solutions
Table 40. Novartis International AG Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Acadia Corporate Information, Location and Competitors
Table 42. Acadia Breakthrough Therapy (BT) Designation Major Business
Table 43. Acadia Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 44. Acadia SWOT Analysis
Table 45. Acadia Breakthrough Therapy (BT) Designation Product and Solutions
Table 46. Acadia Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Eli Lilly Corporate Information, Location and Competitors
Table 48. Eli Lilly Breakthrough Therapy (BT) Designation Major Business
Table 49. Eli Lilly Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 50. Eli Lilly SWOT Analysis
Table 51. Eli Lilly Breakthrough Therapy (BT) Designation Product and Solutions
Table 52. Eli Lilly Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. BMS Corporate Information, Location and Competitors
Table 54. BMS Breakthrough Therapy (BT) Designation Major Business
Table 55. BMS Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 56. BMS SWOT Analysis
Table 57. BMS Breakthrough Therapy (BT) Designation Product and Solutions
Table 58. BMS Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Regeneron Corporate Information, Location and Competitors
Table 60. Regeneron Breakthrough Therapy (BT) Designation Major Business
Table 61. Regeneron Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 62. Regeneron SWOT Analysis
Table 63. Regeneron Breakthrough Therapy (BT) Designation Product and Solutions
Table 64. Regeneron Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Vertex Corporate Information, Location and Competitors
Table 66. Vertex Breakthrough Therapy (BT) Designation Major Business
Table 67. Vertex Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 68. Vertex SWOT Analysis
Table 69. Vertex Breakthrough Therapy (BT) Designation Product and Solutions
Table 70. Vertex Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Jazz Pharmaceuticals Corporate Information, Location and Competitors
Table 72. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Major Business
Table 73. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 74. Jazz Pharmaceuticals SWOT Analysis
Table 75. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Product and Solutions
Table 76. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 78. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Major Business
Table 79. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 80. Boehringer Ingelheim SWOT Analysis
Table 81. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Product and Solutions
Table 82. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Eisai Corporate Information, Location and Competitors
Table 84. Eisai Breakthrough Therapy (BT) Designation Major Business
Table 85. Eisai Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 86. Eisai SWOT Analysis
Table 87. Eisai Breakthrough Therapy (BT) Designation Product and Solutions
Table 88. Eisai Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Alexion Corporate Information, Location and Competitors
Table 90. Alexion Breakthrough Therapy (BT) Designation Major Business
Table 91. Alexion Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 92. Alexion SWOT Analysis
Table 93. Alexion Breakthrough Therapy (BT) Designation Product and Solutions
Table 94. Alexion Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. GlaxoSmithKline Corporate Information, Location and Competitors
Table 96. GlaxoSmithKline Breakthrough Therapy (BT) Designation Major Business
Table 97. GlaxoSmithKline Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 98. GlaxoSmithKline SWOT Analysis
Table 99. GlaxoSmithKline Breakthrough Therapy (BT) Designation Product and Solutions
Table 100. GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Amgen Corporate Information, Location and Competitors
Table 102. Amgen Breakthrough Therapy (BT) Designation Major Business
Table 103. Amgen Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 104. Amgen SWOT Analysis
Table 105. Amgen Breakthrough Therapy (BT) Designation Product and Solutions
Table 106. Amgen Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Exelixis Breakthrough Therapy (BT) Designation Type and Application
Table 108. Exelixis Breakthrough Therapy (BT) Designation Major Business
Table 109. Exelixis Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 110. Exelixis SWOT Analysis
Table 111. Exelixis Breakthrough Therapy (BT) Designation Product and Solutions
Table 112. Exelixis Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Merck Corporate Information, Location and Competitors
Table 114. Merck Breakthrough Therapy (BT) Designation Major Business
Table 115. Merck Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 116. Merck SWOT Analysis
Table 117. Merck Breakthrough Therapy (BT) Designation Product and Solutions
Table 118. Merck Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. AstraZeneca Corporate Information, Location and Competitors
Table 120. AstraZeneca Breakthrough Therapy (BT) Designation Major Business
Table 121. AstraZeneca Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 122. AstraZeneca SWOT Analysis
Table 123. AstraZeneca Breakthrough Therapy (BT) Designation Product and Solutions
Table 124. AstraZeneca Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. Takeda Corporate Information, Location and Competitors
Table 126. Takeda Breakthrough Therapy (BT) Designation Major Business
Table 127. Takeda Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 128. Takeda SWOT Analysis
Table 129. Takeda Breakthrough Therapy (BT) Designation Product and Solutions
Table 130. Takeda Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. Pfizer Corporate Information, Location and Competitors
Table 132. Pfizer Breakthrough Therapy (BT) Designation Major Business
Table 133. Pfizer Breakthrough Therapy (BT) Designation Total Revenue (USD Million) (2017-2018)
Table 134. Pfizer SWOT Analysis
Table 135. Pfizer Breakthrough Therapy (BT) Designation Product and Solutions
Table 136. Pfizer Breakthrough Therapy (BT) Designation Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) by Players (2015-2020)
Table 138. Global Breakthrough Therapy (BT) Designation Revenue Share by Players (2015-2020)
Table 139. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) by Regions (2015-2020)
Table 140. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Regions (2015-2020)
Table 141. North America Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
Table 142. North America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 143. Europe Breakthrough Therapy (BT) Designation Revenue (Million USD) by Countries (2015-2020)
Table 144. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue (Million USD) by Countries (2015-2020)
Table 145. South America Breakthrough Therapy (BT) Designation Revenue by Countries (2015-2020)
Table 146. South America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 147. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue (Million USD) by Countries (2015-2020)
Table 148. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Table 149. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) by Type (2015-2020)
Table 150. Global Breakthrough Therapy (BT) Designation Revenue Share by Type (2015-2020)
Table 151. Global Breakthrough Therapy (BT) Designation Revenue Forecast by Type (2021-2025)
Table 152. Global Breakthrough Therapy (BT) Designation Revenue by Application (2015-2020)
Table 153. Global Breakthrough Therapy (BT) Designation Revenue Share by Application (2015-2020)
Table 154. Global Breakthrough Therapy (BT) Designation Revenue Forecast by Application (2021-2025)
Table 155. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Breakthrough Therapy (BT) Designation Picture
Figure 2. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Type in 2019
Figure 3. Oncology Picture
Figure 4. Infectious Diseases Picture
Figure 5. Rare Diseases Picture
Figure 6. Autoimmune Diseases Picture
Figure 7. Pulmonary Diseases Picture
Figure 8. Neurological Disorders Picture
Figure 9. Others Picture
Figure 10. Breakthrough Therapy (BT) Designation Revenue Market Share by Application in 2019
Figure 11. Hospital Picture
Figure 12. Clinic Picture
Figure 13. Research Institute Picture
Figure 14. Laboratories Picture
Figure 15. Global Breakthrough Therapy (BT) Designation Revenue (USD Million) and Growth Rate (2015-2025)
Figure 16. North America Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Europe Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. South America Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Breakthrough Therapy (BT) Designation Revenue Share by Players in 2019
Figure 23. Global Top 5 Players Breakthrough Therapy (BT) Designation Revenue Market Share in 2019
Figure 24. Global Top 10 Players Breakthrough Therapy (BT) Designation Revenue Market Share in 2019
Figure 25. Key Players Market Share Trend
Figure 26. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 27. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Regions (2015-2020)
Figure 28. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Regions in 2018
Figure 29. North America Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 30. Europe Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 31. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 32. South America Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 33. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 34. North America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Figure 35. North America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries in 2019
Figure 36. USA Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 37. Canada Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 38. Mexico Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 39. Europe Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Figure 40. Europe Breakthrough Therapy (BT) Designation Revenue Market Share by Countries in 2019
Figure 41. Germany Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 42. UK Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 43. France Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 44. Russia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 45. Italy Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Figure 47. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Share by Countries in 2019
Figure 48. China Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 49. Japan Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 50. Korea Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 51. India Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 52. Southeast Asia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 53. South America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Figure 54. South America Breakthrough Therapy (BT) Designation Revenue Market Share by Countries in 2019
Figure 55. Brazil Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 56. Argentina Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 57. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue Market Share by Countries (2015-2020)
Figure 58. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue Market Share by Countries in 2019
Figure 59. Saudi Arabia Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 60. UAE Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 61. Egypt Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 62. South Africa Breakthrough Therapy (BT) Designation Revenue and Growth Rate (2015-2020)
Figure 63. Global Breakthrough Therapy (BT) Designation Revenue Share by Type (2015-2020)
Figure 64. Global Breakthrough Therapy (BT) Designation Revenue Share by Type in 2019
Figure 65. Global Breakthrough Therapy (BT) Designation Market Share Forecast by Type (2021-2025)
Figure 66. Global Oncology Revenue Growth Rate (2015-2020)
Figure 67. Global Infectious Diseases Revenue Growth Rate (2015-2020)
Figure 68. Global Rare Diseases Revenue Growth Rate (2015-2020)
Figure 69. Global Autoimmune Diseases Revenue Growth Rate (2015-2020)
Figure 70. Global Pulmonary Diseases Revenue Growth Rate (2015-2020)
Figure 71. Global Neurological Disorders Revenue Growth Rate (2015-2020)
Figure 72. Global Others Revenue Growth Rate (2015-2020)
Figure 73. Global Breakthrough Therapy (BT) Designation Revenue Share by Application (2015-2020)
Figure 74. Global Breakthrough Therapy (BT) Designation Revenue Share by Application in 2019
Figure 75. Global Breakthrough Therapy (BT) Designation Market Share Forecast by Application (2021-2025)
Figure 76. Global Hospital Revenue Growth Rate (2015-2020)
Figure 77. Global Clinic Revenue Growth Rate (2015-2020)
Figure 78. Global Research Institute Revenue Growth Rate (2015-2020)
Figure 79. Global Laboratories Revenue Growth Rate (2015-2020)
Figure 80. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 81. Global Breakthrough Therapy (BT) Designation Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 82. Global Breakthrough Therapy (BT) Designation Revenue Market Share Forecast by Regions (2021-2025)
Figure 83. North America Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
Figure 84. Europe Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
Figure 85. Asia-Pacific Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
Figure 86. South America Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
Figure 87. Middle East and Africa Breakthrough Therapy (BT) Designation Revenue Market Forecast (2021-2025)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
リソソーム蓄積症治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Lysosomal Storage Diseases Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lysos…- 言語治療サービスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Speech Therapy Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Speech Therapy Servic…
- 画像誘導治療システムの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Image-guided Therapy Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.4% in the forecast period of 2020 to 2025 and will expected to reach USD 3240.3 million by 2025, from USD 2832.6 million in 2019. The Image-g…
- セラピーチェアの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Therapy Chair market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Therapy Chair market report pro…
- スマート圧力療法システムの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Smart Pressure Therapy System market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Smart Pressure …